United States· US:51662-1623_39ae8951-80f9-e2c7-e063-6294a90a4f43
VASOPRESSIN
A medicinal product containing vasopressin, unspecified, registered in United States by HF Acquisition Co LLC, DBA HealthFirst.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- VASOPRESSIN, UNSPECIFIED
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1151662162311 mL in 1 VIAL, MULTI-DOSE (51662-1623-1)
- ndc1151662162321 VIAL, MULTI-DOSE in 1 POUCH (51662-1623-2) / 1 mL in 1 VIAL, MULTI-DOSE
- ndc1151662-1623-1
- ndc1151662-1623-2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ebae0c23-c40c-4be1-9bdb-22488aacfc87 GET /v1/drugs/ebae0c23-c40c-4be1-9bdb-22488aacfc87?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "20",
"substance": "VASOPRESSIN, UNSPECIFIED",
"productndc": "51662-1623",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "[USP'U]/mL",
"application_number": "ANDA214314",
"marketing_category": "ANDA"
}See everything about vasopressin, unspecified.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.